Author: hivecanada
Protected: Watch the latest HIVE session: Drs. Gordon Sussman and Ronald Laxer discuss autoinflammatory diseases [Video 37 min]
Protected: Watch the latest HIVE session: Drs. Gordon Sussman and Susan Waserman discuss the CSU Guidelines [Video 36 min]
Protected: Dr. Moshe Ben-Shoshan provides an overview of the updated urticaria guidelines as presented recently at CSACI 2022 [Video 34 min]
Protected: Watch the third and final video in the series “All Things Urticaria: A Fire Side Chat with Prof. Marcus Maurer” (Part 3 of 3, Video 11 min)
Protected: Watch the second video in the series “All Things Urticaria: A Fire Side Chat with Prof. Marcus Maurer” (Part 2 of 3, Video 4 min)
Protected: Video now available: “All Things Urticaria: A Fire Side Chat with Prof. Marcus Maurer” (Part 1 of 3, Video 15 min)
The Buzz, Issue #15 is now out! This month, we highlight a survey of Canadian practice patterns in atopic dermatitis, a Canadian position statement on preventing food allergy in high-risk infants, and the World Allergy Organization’s guidelines on immunotherapy for cow’s milk allergy. We also feature a Canadian survey of attitudes towards COVID-19 vaccination among patients with primary immunodeficiency and look into the sensitivity and specificity of using TPO and IgE as diagnostic biomarkers for autoimmune CSU.
The Buzz Issue #15, July 2022 edition, will be sent to all HIVE members by email on Mon, June 27th, and can be accessed online here.
To view all issues of The Buzz, go to thehivecommunity.org/the-buzz
Protected: Whiteboard Video #1: Dr. Sari Herman presents the first of a three-part animated video series on diagnosis and treatment for patients with chronic urticaria (EN & FR, video 2 min)
The Buzz, Issue #14 is now out! In this month’s issue, we highlight a possible new predictive biomarker for severe anaphylaxis in children, the use of direct oral challenge to de-label penicillin allergy during pregnancy, and three publications in atopic dermatitis: new data with the JAK1-selective inhibitor abrocitinib, a structured appraisal of the clinical practice guidelines, and a metaanalysis of the literature on the use of dilute bleach baths.
The Buzz Issue #14, June 2022 edition, will be sent to all HIVE members by email on Mon, May 30th, and can be accessed online here.
To view all issues of The Buzz, go to thehivecommunity.org/the-buzz
The HIVE Community 